Clinical Trial Update: Treatment of Congenital Factor VII Deficiency

View source ↗

Summary

A completed clinical trial sponsored by Novo Nordisk evaluated treatment for congenital Factor VII deficiency. The study status is listed as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Factor Vii Deficiency

Drugs mentioned

• NovoSeven RT (Recombinant activated factor VII)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Congenital FVII Deficiency | Status: COMPLETED